Home›People›Nick Spring
Nick Spring

Nick Spring

Business Strategy & Commercialization at Merlin Biotech.

Executive
Updated Nov 9, 2026·Latest SEC filing Aug 11, 2026·Suggest an edit

About Nick Spring

Nick Spring is a business strategy & commercialization at Merlin Biotech.

Experience

This experience comes from SEC filings. The years are when the filings name Nick Spring in the role, so the role may have started earlier or lasted longer.

Merlin Biotech, Inc.
Business Strategy & Commercialization
2026 · Doylestown, PA
Develops potential cancer treatments for adults and children using messenger RNA.

Key Colleagues at Startups

The people Nick Spring works with at each company, as listed on that company's latest Form D.

Merlin Biotech, Inc. · Form D, Aug 11, 2026
Randall Hyer
Randall Hyer
Chief Executive Officer and director
JB
Jay Bhatia
Director
NH
Nikhil Heble
Executive officer
Loren Danzis
Loren Danzis
Partner, Fox Rothschild LLP and director

Sources

  1. SECMerlin Biotech, Inc. Form D, filed Aug 11, 2026